Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012.
Publication
, Journal Article
Hoffman, KB; Demakas, A; Erdman, CB; Dimbil, M; Doraiswamy, PM
Published in: BMJ
July 23, 2013
Duke Scholars
Published In
BMJ
DOI
EISSN
1756-1833
Publication Date
July 23, 2013
Volume
347
Start / End Page
f4656
Location
England
Related Subject Headings
- United States Food and Drug Administration
- United States
- Substance-Related Disorders
- Product Surveillance, Postmarketing
- Oseltamivir
- Mental Disorders
- Humans
- General & Internal Medicine
- Drug Approval
- Data Mining
Citation
APA
Chicago
ICMJE
MLA
NLM
Hoffman, K. B., Demakas, A., Erdman, C. B., Dimbil, M., & Doraiswamy, P. M. (2013). Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012. BMJ, 347, f4656. https://doi.org/10.1136/bmj.f4656
Hoffman, Keith B., Andrea Demakas, Colin B. Erdman, Mo Dimbil, and P Murali Doraiswamy. “Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012.” BMJ 347 (July 23, 2013): f4656. https://doi.org/10.1136/bmj.f4656.
Hoffman KB, Demakas A, Erdman CB, Dimbil M, Doraiswamy PM. Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012. BMJ. 2013 Jul 23;347:f4656.
Hoffman, Keith B., et al. “Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012.” BMJ, vol. 347, July 2013, p. f4656. Pubmed, doi:10.1136/bmj.f4656.
Hoffman KB, Demakas A, Erdman CB, Dimbil M, Doraiswamy PM. Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012. BMJ. 2013 Jul 23;347:f4656.
Published In
BMJ
DOI
EISSN
1756-1833
Publication Date
July 23, 2013
Volume
347
Start / End Page
f4656
Location
England
Related Subject Headings
- United States Food and Drug Administration
- United States
- Substance-Related Disorders
- Product Surveillance, Postmarketing
- Oseltamivir
- Mental Disorders
- Humans
- General & Internal Medicine
- Drug Approval
- Data Mining